Retrospective study compares clinical features of chlamydia pneumoniae and mycoplasma pneumoniae, highlighting risk factors for severe pneumonia.
Key Points
Children hospitalized with chlamydia pneumoniae pneumonia were older and had more symptoms than those with mycoplasma pneumoniae pneumonia.
Laboratory tests indicated higher white blood cell and eosinophil counts in chlamydia pneumoniae pneumonia patients compared to mycoplasma pneumoniae pneumonia patients.
Severe cases of chlamydia pneumoniae pneumonia constituted 6.8% of all cases, with eosinophil count identified as a potential biomarker for its severity.
The number of children hospitalized with chlamydia pneumoniae pneumonia increased significantly in 2024 compared to 2023, indicating a rising trend.